Maxwell Skor

Stock Analyst at Morgan Stanley

(n/a)

# 4,471

Out of 4,786 analysts

3

Total ratings

n/a

Success rate

-41.01%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Maxwell Skor

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	TCRX TScan Therapeutics	Assumes: Overweight	$10	$1.38	+624.64%	1	Mar 14, 2025
	IVVD Invivyd	Maintains: Overweight	$9.5 → $3.55	$0.61	+486.49%	2	Nov 20, 2024

TScan Therapeutics

Mar 14, 2025

Assumes: Overweight

Price Target: $10

Current: $1.38

Upside: +624.64%

Invivyd

Nov 20, 2024

Maintains: Overweight

Price Target: $9.5 → $3.55

Current: $0.61

Upside: +486.49%